Mettler-Toledo International (NYSE:MTD) Upgraded by Citigroup to "Buy" Rating

Citigroup upgraded shares of Mettler-Toledo International (NYSE:MTD - Free Report) from a neutral rating to a buy rating in a report published on Monday, MarketBeat.com reports. Citigroup currently has $1,400.00 price target on the medical instruments supplier's stock.

Several other analysts also recently commented on the stock. Robert W. Baird increased their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a "neutral" rating in a research report on Monday, February 10th. Evercore ISI increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an "outperform" rating in a research report on Monday, February 10th. Wolfe Research began coverage on Mettler-Toledo International in a research report on Friday, December 13th. They issued a "peer perform" rating on the stock. Finally, Wells Fargo & Company boosted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an "equal weight" rating in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $1,380.50.

Remove Ads

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded up $43.57 during mid-day trading on Monday, reaching $1,041.26. 324,135 shares of the company traded hands, compared to its average volume of 138,835. The firm's 50 day moving average price is $1,217.84 and its 200 day moving average price is $1,275.83. The firm has a market capitalization of $21.70 billion, a price-to-earnings ratio of 25.69, a P/E/G ratio of 3.30 and a beta of 1.28. Mettler-Toledo International has a 52-week low of $946.69 and a 52-week high of $1,546.93.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last announced its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. On average, sell-side analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Buying and Selling

In other Mettler-Toledo International news, insider Christian Magloth sold 790 shares of the firm's stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, insider Gerry Keller sold 600 shares of the business's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the completion of the sale, the insider now owns 6 shares in the company, valued at $8,108.04. This represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Hedge Funds Weigh In On Mettler-Toledo International

Institutional investors and hedge funds have recently modified their holdings of the stock. JPMorgan Chase & Co. lifted its stake in Mettler-Toledo International by 14.7% in the third quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier's stock worth $332,634,000 after purchasing an additional 28,478 shares during the last quarter. M&T Bank Corp increased its stake in shares of Mettler-Toledo International by 14.3% during the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier's stock valued at $7,387,000 after buying an additional 615 shares during the period. Allworth Financial LP raised its holdings in shares of Mettler-Toledo International by 367.4% in the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier's stock valued at $285,000 after acquiring an additional 169 shares in the last quarter. Nordea Investment Management AB lifted its stake in Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier's stock worth $129,919,000 after acquiring an additional 24,285 shares during the period. Finally, Robeco Institutional Asset Management B.V. grew its holdings in Mettler-Toledo International by 18.0% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier's stock worth $42,058,000 after acquiring an additional 5,234 shares in the last quarter. Hedge funds and other institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.